Medical Devices · Minneapolis, Minnesota, United States
$5.16
-1.34% (-$0.07)2026-07-09
Smart-Money SignalNeutral · 52/100— Insider open-market flow is flat over 90 days
Revenue$14.8M
Net Income-$13.1M
EPS$-0.50
Gross Margin87.2%
Market Cap$136.4M
Price Performance
Historical data including institutional events
Company Profile
K
Kevin Hykes
CEO & Executive Director
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.
The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
